StockComparison Logo
vs

CRDL vs ENGN

Comparison between Cardiol Therapeutics Inc - Class A (CRDL, Company) and enGene Holdings Inc (ENGN, Company).

Both CRDL and ENGN are from the Healthcare sector.

CRDL vs ENGN - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
CRDL
$116M
ENGN
$115M
Max Drawdown
Winner
CRDL
92.71%
ENGN
92.80%
Sharpe Ratio
CRDL
-0.08
Winner
ENGN
0.46
5Y Beta
CRDL
1.31
Winner
ENGN
0.88
Industry
CRDL
Drug Manufacturers - Specialty & Generic
ENGN
Biotechnology
P/E Ratio
Winner
CRDL
-3.75
ENGN
-0.79
PEG Ratio
CRDL
N/A
ENGN
-0.02
5Y EPS CAGR
CRDL
-10.43%
ENGN
N/A
Debt to Equity
CRDL
0.48%
Winner
ENGN
0.00%
Free Cash Flow Yield
Winner
CRDL
-15.22%
ENGN
-96.67%

CRDL vs ENGN - Historical Returns

Returns include dividend reinvestment.

1M
CRDL
-17.19%
Winner
ENGN
+9.55%
3M
Winner
CRDL
+7.41%
ENGN
-76.04%
6M
Winner
CRDL
+4.95%
ENGN
-78.95%
1Y
Winner
CRDL
-19.70%
ENGN
-47.72%
5Y(CAGR)
CRDL
-14.72%
ENGN
N/A
Max(CAGR)
Winner
CRDL
-15.63%
ENGN
-60.68%

CRDL vs ENGN - Annual Returns (2019 - 2026)

Returns include dividend reinvestment.

YearCRDLENGN
2026+6.62%-80.56%
2025-30.38%+27.90%
2024+45.45%-27.40%
2023+56.12%-53.85%
2022-72.58%N/A
2021-13.65%N/A
2020-39.59%N/A
2019-5.49%N/A

CRDL vs ENGN Drawdown Comparison

The maximum drawdown for CRDL was -92.71%, occurring on Apr 5, 2023. This drawdown has not yet recovered.

The maximum drawdown for ENGN was -92.80%, occurring on May 12, 2026. This drawdown has not yet recovered.

The current CRDL drawdown is -82.88%. The current ENGN drawdown is -91.40%.

RankCRDLENGN
#1-92.71%
Feb 22, 2019 - Apr 5, 2023
-92.80%
Nov 1, 2023 - May 12, 2026
#2-9.26%
Feb 4, 2019 - Feb 19, 2019
N/A
#3-1.86%
Jan 18, 2019 - Jan 29, 2019
N/A
#4-0.20%
Jan 16, 2019 - Jan 18, 2019
N/A

Correlation

Correlation between CRDL and ENGN is 0.44 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.44
-101

Select Stocks to Compare